These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37365772)

  • 1. Comment on: "Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia".
    Dar MS
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30532. PubMed ID: 37365772
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment adherence in patients with sickle cell anemia.
    Drotar D
    J Pediatr; 2010 Mar; 156(3):350-1. PubMed ID: 20056235
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: Comment on: "Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia".
    Reeves SL; Dombkowski KJ; Peng HK; Phan H; Kolenic G; Creary SE; Madden B; Lisabeth L
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30630. PubMed ID: 37592368
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.
    Brandow AM; Panepinto JA
    Am J Hematol; 2011 Sep; 86(9):804-6. PubMed ID: 21815183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea use among children with sickle cell anemia.
    Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27721. PubMed ID: 30900800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.
    Strouse JJ; Heeney MM
    Pediatr Blood Cancer; 2012 Aug; 59(2):365-71. PubMed ID: 22517797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?
    Aygun B
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28164. PubMed ID: 31925887
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: Effects of hydroxyurea on brain function in children with sickle cell anemia.
    Hayat A; Chaudhry HUR; Ahmad A
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29624. PubMed ID: 35471593
    [No Abstract]   [Full Text] [Related]  

  • 9. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study.
    Creary S; Chisolm D; Stanek J; Hankins J; O'Brien SH
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13452. PubMed ID: 31397291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to hydroxyurea therapy in children with sickle cell anemia.
    Thornburg CD; Calatroni A; Telen M; Kemper AR
    J Pediatr; 2010 Mar; 156(3):415-9. PubMed ID: 19880135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea marketed for sickle cell anemia.
    Am J Health Syst Pharm; 1998 May; 55(9):875. PubMed ID: 9588244
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea Initiation Among Children With Sickle Cell Anemia.
    Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
    Clin Pediatr (Phila); 2019 Nov; 58(13):1394-1400. PubMed ID: 31113236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical Neglect by Underprescription and Underutilization of Hydroxyurea in Children with Sickle Cell Disease.
    Rana S
    South Med J; 2016 Sep; 109(9):503-5. PubMed ID: 27598349
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term use of hydroxyurea for sickle cell anemia.
    Lee DA; Mueller BU
    JAMA; 2003 Aug; 290(6):753-4; author reply 754. PubMed ID: 12915425
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE; Gladwin MT; Byrne M; Hildesheim M; Krishnamurti L
    Pediatr Blood Cancer; 2014 Jun; 61(6):1068-73. PubMed ID: 24436121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
    Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
    Zahr RS; Hankins JS; Kang G; Li C; Wang WC; Lebensburger J; Estepp JH
    Am J Hematol; 2019 Jan; 94(1):E27-E29. PubMed ID: 30359463
    [No Abstract]   [Full Text] [Related]  

  • 20. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
    Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.